These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25243597)

  • 21. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
    Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.
    Amati-Bonneau P; Guichet A; Olichon A; Chevrollier A; Viala F; Miot S; Ayuso C; Odent S; Arrouet C; Verny C; Calmels MN; Simard G; Belenguer P; Wang J; Puel JL; Hamel C; Malthièry Y; Bonneau D; Lenaers G; Reynier P
    Ann Neurol; 2005 Dec; 58(6):958-63. PubMed ID: 16240368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural history of OPA1-related autosomal dominant optic atrophy.
    Cohn AC; Toomes C; Hewitt AW; Kearns LS; Inglehearn CF; Craig JE; Mackey DA
    Br J Ophthalmol; 2008 Oct; 92(10):1333-6. PubMed ID: 18653586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy.
    Fuhrmann N; Alavi MV; Bitoun P; Woernle S; Auburger G; Leo-Kottler B; Yu-Wai-Man P; Chinnery P; Wissinger B
    J Med Genet; 2009 Feb; 46(2):136-44. PubMed ID: 19181907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families.
    Pretegiani E; Rosini F; Rufa A; Gallus GN; Cardaioli E; Da Pozzo P; Bianchi S; Serchi V; Collura M; Franceschini R; Bianchi Marzoli S; Dotti MT; Federico A
    J Neurol Sci; 2017 Nov; 382():29-35. PubMed ID: 29111013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-onset Behr syndrome due to compound heterozygous mutations in OPA1.
    Bonneau D; Colin E; Oca F; Ferré M; Chevrollier A; Guéguen N; Desquiret-Dumas V; N'Guyen S; Barth M; Zanlonghi X; Rio M; Desguerre I; Barnerias C; Momtchilova M; Rodriguez D; Slama A; Lenaers G; Procaccio V; Amati-Bonneau P; Reynier P
    Brain; 2014 Oct; 137(Pt 10):e301. PubMed ID: 25012220
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.
    Li H; Jones EM; Li H; Yang L; Sun Z; Yuan Z; Chen R; Dong F; Sui R
    Ophthalmic Genet; 2018 Oct; 39(5):569-576. PubMed ID: 29952689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy.
    Dadgar S; Hagens O; Dadgar SR; Haghighi EN; Schimpf S; Wissinger B; Garshasbi M
    Exp Eye Res; 2006 Sep; 83(3):702-6. PubMed ID: 16698014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.
    Cohn AC; Toomes C; Potter C; Towns KV; Hewitt AW; Inglehearn CF; Craig JE; Mackey DA
    Am J Ophthalmol; 2007 Apr; 143(4):656-62. PubMed ID: 17306754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OPA1-associated disorders: phenotypes and pathophysiology.
    Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
    Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
    J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder.
    Liskova P; Ulmanova O; Tesina P; Melsova H; Diblik P; Hansikova H; Tesarova M; Votruba M
    Acta Ophthalmol; 2013 May; 91(3):e225-31. PubMed ID: 23387428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations.
    Nasca A; Rizza T; Doimo M; Legati A; Ciolfi A; Diodato D; Calderan C; Carrara G; Lamantea E; Aiello C; Di Nottia M; Niceta M; Lamperti C; Ardissone A; Bianchi-Marzoli S; Iarossi G; Bertini E; Moroni I; Tartaglia M; Salviati L; Carrozzo R; Ghezzi D
    Orphanet J Rare Dis; 2017 May; 12(1):89. PubMed ID: 28494813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.
    Votruba M; Thiselton D; Bhattacharya SS
    Br J Ophthalmol; 2003 Jan; 87(1):48-53. PubMed ID: 12488262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The G401D mutation of OPA1 causes autosomal dominant optic atrophy and hearing loss in a Chinese family.
    Ke T; Nie SW; Yang QB; Liu JP; Zhou LN; Ren X; Liu JY; Wang Q; Liu MG
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):481-5. PubMed ID: 17029191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenicity evaluation and the genotype-phenotype analysis of OPA1 variants.
    Xu X; Wang P; Jia X; Sun W; Li S; Xiao X; Hejtmancik JF; Zhang Q
    Mol Genet Genomics; 2021 Jul; 296(4):845-862. PubMed ID: 33884488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biallelic Optic Atrophy 1 (
    Othman BA; Ong JE; Dumitrescu AV
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial disorder with OPA1 mutation lacking optic atrophy.
    Milone M; Younge BR; Wang J; Zhang S; Wong LJ
    Mitochondrion; 2009 Jul; 9(4):279-81. PubMed ID: 19303950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations.
    Schaaf CP; Blazo M; Lewis RA; Tonini RE; Takei H; Wang J; Wong LJ; Scaglia F
    Mol Genet Metab; 2011 Aug; 103(4):383-7. PubMed ID: 21636302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leigh-like neuroimaging features associated with new biallelic mutations in OPA1.
    Rubegni A; Pisano T; Bacci G; Tessa A; Battini R; Procopio E; Giglio S; Pasquariello R; Santorelli FM; Guerrini R; Nesti C
    Eur J Paediatr Neurol; 2017 Jul; 21(4):671-677. PubMed ID: 28442211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.